SCHEMBL24120239

SCHEMBL24120239

CO[C@H]1OC(CF)(COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.34
SSTR1 P30872 1/20 0.34
SSTR2 P30874 1/20 0.34
SSTR4 P31391 1/20 0.34
SSTR3 P32745 1/20 0.34
SSTR5 P35346 1/20 0.34
GRM2 Q14416 1/20 0.33
GRM3 Q14832 1/20 0.33
LGALS8 O00214 1/20 0.33
PSEN1 P49768 3/20 0.33
PSEN2 P49810 3/20 0.33
APH1B Q8WW43 3/20 0.33
NCSTN Q92542 3/20 0.33
APH1A Q96BI3 3/20 0.33
PSENEN Q9NZ42 3/20 0.33
TSHR P16473 1/20 0.33
IDO1 P14902 1/20 0.32
PDE4D Q08499 1/20 0.32
LGALS3 P17931 1/20 0.32
GJB2 P29033 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819176 1.00 BCHE (0.34) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL23922552 1.00 BCHE (0.34) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL23818771 0.93 SSTR1 (0.36) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL703496 0.89 BCHE (0.36) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL26626297 0.87 LGALS8 (0.37) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL20819157 0.87 SSTR1 (0.39) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL22392937 0.87 SSTR1 (0.39) BCHESSTR1SSTR2SSTR4SSTR3
SCHEMBL25433232 0.85 TSHR (0.36) BCHEGRM2GRM3TSHRIDO1
SCHEMBL26135309 0.85 TSHR (0.36) BCHEGRM2GRM3TSHRIDO1
SCHEMBL704560 0.84 BCHE (0.34) BCHESSTR1SSTR2SSTR4SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773126-B2 Substituted nucleosides, nucleotides and analogs thereof Janssen Pharmaceuticals, Inc. (US) 2023-10-03 US disclosed
US-20210395288-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALAOGS THEREOF JANSSSEN BIOPHARMA, INC. (US) 2021-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773126-B2 Substituted nucleosides, nucleotides and analogs thereof PNP, TYMP, SLC29A1 BCHE 1878/4885SSTR1 2885/4885SSTR2 3793/4885
US-20210395288-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALAOGS THEREOF PNP, RNGTT, NT5C3B BCHE 1693/4885SSTR1 3535/4885SSTR2 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.